Molecule Details
| InChIKey | GUJPHYMIQHZGDO-JOCHJYFZSA-N |
|---|---|
| Compound Name | 2,2-diethyl-N-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-N'-propylpropanediamide |
| Canonical SMILES | CCCNC(=O)C(CC)(CC)C(=O)N[C@H]1N=C(c2ccccc2)c2ccccc2N(C)C1=O |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 6 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.64 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
Target Activities (6)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P49768 | PSEN1 | Homo sapiens | Human | PF01080 | 6.6 | Ki | ChEMBL;BindingDB |
| P49810 | PSEN2 | Homo sapiens | Human | PF01080 | 6.6 | Ki | ChEMBL |
| Q8WW43 | APH1B | Homo sapiens | Human | PF06105 | 6.6 | Ki | ChEMBL |
| Q92542 | NCSTN | Homo sapiens | Human | PF18266 PF05450 | 6.6 | Ki | ChEMBL |
| Q96BI3 | APH1A | Homo sapiens | Human | PF06105 | 6.6 | Ki | ChEMBL |
| Q9NZ42 | PSENEN | Homo sapiens | Human | PF10251 | 6.6 | Ki | ChEMBL |